KB, L., EB, A., BM, G., KA, B., A, S., & RJ, K. (2021). Comparison of the predictive value of area under the curve versus maximum serum concentration of intravenous tobramycin in cystic fibrosis patients treated for an acute pulmonary exacerbation. Pediatric pulmonology, 56(10), 3209. https://doi.org/10.1002/ppul.25569
Chicago Style (17th ed.) CitationKB, Landmesser, Autry EB, Gardner BM, Bosko KA, Schadler A, and Kuhn RJ. "Comparison of the Predictive Value of Area Under the Curve Versus Maximum Serum Concentration of Intravenous Tobramycin in Cystic Fibrosis Patients Treated for an Acute Pulmonary Exacerbation." Pediatric Pulmonology 56, no. 10 (2021): 3209. https://doi.org/10.1002/ppul.25569.
MLA (9th ed.) CitationKB, Landmesser, et al. "Comparison of the Predictive Value of Area Under the Curve Versus Maximum Serum Concentration of Intravenous Tobramycin in Cystic Fibrosis Patients Treated for an Acute Pulmonary Exacerbation." Pediatric Pulmonology, vol. 56, no. 10, 2021, p. 3209, https://doi.org/10.1002/ppul.25569.